|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Flexion Therapeutics (NASDAQ: FLXN) through any online brokerage.
The latest price target for Flexion Therapeutics (NASDAQ: FLXN) was reported by HC Wainwright & Co. on October 19, 2021. The analyst firm set a price target for 10.00 expecting FLXN to rise to within 12 months (a possible 7.41% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Flexion Therapeutics (NASDAQ: FLXN) is $9.31 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Flexion Therapeutics.
Flexion Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Flexion Therapeutics.
Flexion Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.